Soheil Tavakolpour (S Tavakolpour)

Publication Activity (10 Years)

Years Active: 2017-2022
Publications (10 Years): 35

Top Topics

Monoclonal Antibody

Chronic Lymphocytic Leukemia

Ejection Fraction

Clinical Evaluation

Top Venues

Dermatologic therapy

The Journal of dermatological treatment

Archives of dermatological research

International journal of dermatology

This page only lists publications with an associated author ORCID identifier.

Publications

Ifa Etesami, Yasamin Kalantari, Soheil Tavakolpour, Hamid Reza Mahmoudi, Maryam Danespazhooh
Drug-induced cutaneous pseudolymphoma: A systematic review of the literature. The Australasian journal of dermatology (2022)
Elham Daneshvar, Soheil Tavakolpour, Hamidreza Mahmoudi, Maryam Danespazhooh, Amir Teimourpour, Saeed Aslani, Kamran Balighi
Elevated serum level of B-cell activating factor (BAFF) after rituximab therapy in pemphigus vulgaris patients suggests a possible therapeutic efficacy of B-cell depletion therapies combined with anti-BAFF agents. International journal of dermatology (2022)
Kamran Balighi, Cheida Shams-Davatchi, Salar Ghobadi, Maryam Danespazhooh, Vahide Lajevardi, Hamid Reza Mahmoudi, Zeinab Aryanian, Amir Teymourpour, Ramtin Seirafi, Fereshteh Beigmohammadi, Soheil Tavakolpour
Retrospective study of gingival involvement in pemphigus: A difficult to treat phenomenon. Dermatologic therapy 35 (6) (2022)
Sara Mahdiabadi, Fateme Rajabi, Soheil Tavakolpour, Nima Rezaei
Immunological aspects of COVID-19-related skin manifestations: Revisiting pathogenic mechanism in the light of new evidence. Dermatologic therapy 35 (10) (2022)
Hannaneh Faraji, Maryam Danespazhooh, Amir Hooshang Ehsani, Hamid Reza Mahmoudi, Soheil Tavakolpour, Zeinab Aryanian, Saeed Aslani, Hamidreza Khodaveisi, Kamran Balighi
Evaluating the risk-to-benefit ratio of using cotrimoxazole as a Pneumocystis pneumonia preventative intervention among pemphigus patients treated with rituximab: a retrospective study with 494 patients. Dermatologic therapy (2021)
Seyed Mohammad Piri, Maryam Edalatfar, Sina Shool, Mohammad Naser Jalalian, Soheil Tavakolpour
A systematic review on the recurrence of SARS-CoV-2 virus: frequency, risk factors, and possible explanations. Infectious diseases (London, England) 53 (5) (2021)
Hamid Reza Mahmoudi, Ali Nili, Ali Salehi Farid, Soheil Tavakolpour, Maryam Danespazhooh
Paradoxical worsening of pemphigus after rituximab presenting as figurate bullous eruption. The British journal of dermatology 185 (1) (2021)
Maryam Danespazhooh, Soheil Tavakolpour, Ali Salehi Farid, Mehrnoosh Ebadi, Ali Nili, Mohammad Rashidian, Hamid Reza Mahmoudi
Pustular eruption after biosimilar rituximab infusion: report of acute generalized exanthematous pustulosis in two patients with pemphigus. International journal of dermatology 61 (1) (2021)
Ali Nili, Ali Salehi Farid, Masoud Asgari, Soheil Tavakolpour, Hamid Reza Mahmoudi, Maryam Danespazhooh
Current status and prospects for the diagnosis of pemphigus vulgaris. Expert review of clinical immunology 17 (8) (2021)
Soheil Tavakolpour, Zeinab Aryanian, Farnoosh Seirafianpour, Milad Dodangeh, Ifa Etesami, Maryam Danespazhooh, Kamran Balighi, Hamid Reza Mahmoudi, Azadeh Goodarzi
A systematic review on efficacy, safety, and treatment-durability of low-dose rituximab for the treatment of Pemphigus: special focus on COVID-19 pandemic concerns. Immunopharmacology and immunotoxicology 43 (5) (2021)
Hamid Reza Mahmoudi, Soheil Tavakolpour, Ali Nili, Ali Salehi Farid, Maryam Danespazhooh, Mohammad Rashidian
Treatment of pemphigus patients in the COVID-19 era: A specific focus on rituximab. Dermatologic therapy 33 (6) (2020)
Hamid Reza Mahmoudi, Soheil Tavakolpour, Shadi Azizzadeh-Roodpishi, Maryam Danespazhooh
Desquamative gingivitis in a pemphigus vulgaris patient resistant to rituximab. Dermatologic therapy 33 (2) (2020)
Ali Nili, Soheil Tavakolpour, Hamid Reza Mahmoudi, Pedram Noormohammadpour, Kamran Balighi, Maryam Daneshpazhooh
Paradoxical reaction to rituximab in patients with pemphigus: a report of 10 cases. Immunopharmacology and immunotoxicology 42 (1) (2020)
Borzouyeh Sadeghi, Ali Nili, Soheil Tavakolpour, Kamran Balighi, Maryam Danespazhooh, Hamid Reza Mahmoudi
Concomitant bullous pemphigoid and palmoplantar keratoderma: A report of three cases and review of literature. Dermatologic therapy 33 (6) (2020)
Zeinab Gholibeigian, Maryam Izad, Maryam Danespazhooh, Hossein Mortazavi, Zahra Salehi, Shirin Behruzifar, Marwa Akhdar, Soheil Tavakolpour, Arghavan Azizpour
Decreased serum levels of interleukin-17, interleukin-23, TGF-β in pemphigus vulgaris patients, and their association with disease phase. Dermatologic therapy 33 (6) (2020)
Ali Salehi Farid, Somayeh Niknam, Kheirollah Gholami, Soheil Tavakolpour, Amir Teimourpour, Maryam Danespazhooh, Ali Nili, Arghavan Azizpour, Maryam Nasimi, Hamid Reza Mahmoudi
Comparing efficacy and safety of potassium hydroxide 5% solution with 5-fluorouracil cream in patients with actinic keratoses: a randomized controlled trial. The Journal of dermatological treatment (2020)
Nika Kianfar, Shayan Dasdar, Hamid Reza Mahmoudi, Soheil Tavakolpour, Kamran Balighi, Maryam Danespazhooh
Rituximab in childhood and juvenile autoimmune bullous diseases as first-line and second-line treatment: a case series of 13 patients. The Journal of dermatological treatment (2020)
Nika Kianfar, Shayan Dasdar, Hamid Reza Mahmoudi, Soheil Tavakolpour, Kamran Balighi, Maryam Danespazhooh
Lichen planus-like lesions in 36 patients with pemphigus: A cross-sectional study. Oral diseases 27 (4) (2020)
Ali Nili, Hamid Reza Mahmoudi, Nikta Heidari, Soheil Tavakolpour, Ali Salehi Farid, Kamran Balighi, Maryam Danespazhooh
Rituximab monotherapy in mild pemphigus. The Journal of dermatological treatment (2020)
Hamid Reza Mahmoudi, Soheil Tavakolpour, Kamran Balighi, Ali Salehi Farid, Ali Nili, Delnavaz Jan, Maryam Danespazhooh
Rituximab in practice: Clinical evaluation of patients with pemphigus after rituximab administration. Dermatologic therapy 34 (1) (2020)
Hamid Reza Mahmoudi, Anahita Rostami, Soheil Tavakolpour, Ali Nili, Amir Teimourpour, Ali Salehi Farid, Robabeh Abedini, Mohammad Amini, Maryam Danespazhooh
Oral isotretinoin combined with topical clobetasol 0.05% and tacrolimus 0.1% for the treatment of frontal fibrosing alopecia: a randomized controlled trial. The Journal of dermatological treatment (2020)
Mahsa Fallahi, Zahra Hallaji, Soheil Tavakolpour, Somayeh Niknam, Ali Salehi Farid, Ali Nili, Amir Teimourpour, Maryam Danespazhooh, Javad Rahmati, Shahriar Haddady Abianeh, Hamid Reza Mahmoudi
Evaluating the efficacy and safety of topical sirolimus 0.2% cream as adjuvant therapy with pulsed dye laser for the treatment of port wine stain: A randomized, double-blind, placebo-controlled trial. Journal of cosmetic dermatology 20 (8) (2020)
Fereshteh Salarvand, Zahra Fatehi, Maryam Shahali, Kamran Balighi, Maryam Ghiasi, Robabeh Abedini, Hamid Reza Mahmoudi, Soheil Tavakolpour, Cheyda Chams-Davatchi, Maryam Danespazhooh
"Change over time in the treatment of pemphigus vulgaris between 2004 and 2016 in Iran": A multiple cross-sectional study. Dermatologic therapy 32 (2) (2019)
Maryam Danespazhooh, Kamran Balighi, Hamid Reza Mahmoudi, Soheil Tavakolpour, Robabeh Abedini, Tahereh Soori, Amir-Houshang Ehsani, Maryam Ghiasi, Pedram Noormohammadpour, Narges Ghandi, Vahideh Lajevardi, Ali Sadeghinia, Maryam Nasimi, Arghavan Azizpour, Cheyda Chams-Davatchi
Iranian guideline for rituximab therapy in pemphigus patients. Dermatologic therapy 32 (5) (2019)
HamidReza Mahmoudi, Elaheh Ebrahimi, Maryam Daneshpazhooh, Kamran Balighi, Azin Mirzazadeh, Somayeh Elikaei Behjati, Soheil Tavakolpour
Single-nucleotide polymorphisms associated with pemphigus vulgaris: Potent markers for better treatment and personalized medicine. International journal of immunogenetics 47 (1) (2019)
Hamid Reza Mahmoudi, Soheil Tavakolpour, Kamran Balighi, Amir Teimourpour, Seyede-Zahra Ghodsi, Robabeh Abedini, Narges Ghandi, Vahideh Lajevardi, Amin Kiani, Kambiz Kamyab, Mohammadreza Mohammadi, Maryam Danespazhooh
Lichen planopilaris: retrospective study on the characteristics and treatment of 291 patients. The Journal of dermatological treatment 30 (6) (2019)
Ali Sadeghinia, Saba Moghaddas, Soheil Tavakolpour, Amir Teimourpour, Maryam Danespazhooh, Hamid Reza Mahmoudi
Treatment of port wine stains with 595-nm pulsed dye laser in 27 pediatric patients: A prospective study in the Iranian population. Journal of cosmetic and laser therapy : official publication of the European Society for Laser Dermatology 21 (7-8) (2019)
Yasaman Ketabi, Soheila Nasiri, Maedeh Kheirodin, Soheil Tavakolpour, Nikoo Mozafari
The elevated level of osteopontin in patients with pemphigus vulgaris: A cytokine-like protein with a therapeutic potential. Dermatologic therapy 32 (4) (2019)
Soheil Tavakolpour, M Darvishi, M Ghasemiadl
Pharmacogenetics: A strategy for personalized medicine for autoimmune diseases. Clinical genetics 93 (3) (2019)
Kamran Balighi, Maryam Daneshpazhooh, HamidReza Mahmoudi, Mehrnoosh Badakhsh, Amir Teimourpour, Amir Houshang Ehsani, Arghavan Azizpour, Zahra Akbari, Mostafa Mahdavinia, Mojtaba Ghasemiadl, Soheil Tavakolpour
Comparing early and late treatments with rituximab in pemphigus vulgaris: which one is better? Archives of dermatological research 311 (1) (2018)
Kamran Balighi, Maryam Danespazhooh, Zahra Akbari, Soheil Tavakolpour, Pourya Azimi, Arghavan Azizpour
Comparing the short-term therapeutic effects and safety profiles of rituximab therapy in pemphigus vulgaris patients either early treated or later than six months. The Journal of dermatological treatment 30 (4) (2018)
Soheil Tavakolpour
Tofacitinib as the potent treatment for refractory pemphigus: A possible alternative treatment for pemphigus. Dermatologic therapy 31 (5) (2018)
Kamran Balighi, Roya-Sadaat Sakhi, Maryam Danespazhooh, Hamid Reza Mahmoudi, Amir Teimourpour, Soheil Tavakolpour
Anti-desmoglein-1 levels as predictor of prednisolone tapering in pemphigus vulgaris patients treated with rituximab. Dermatologic therapy 31 (6) (2018)
Soheil Tavakolpour, Somayeh Elkaei Behjati
The ignored roles of microRNAs in alopecia areata. Dermatologic therapy 30 (4) (2017)
Soheil Tavakolpour
Pemphigus trigger factors: special focus on pemphigus vulgaris and pemphigus foliaceus. Archives of dermatological research 310 (2) (2017)